pubmed-article:18478111 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18478111 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:18478111 | lifeskim:mentions | umls-concept:C0006118 | lld:lifeskim |
pubmed-article:18478111 | lifeskim:mentions | umls-concept:C0851346 | lld:lifeskim |
pubmed-article:18478111 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
pubmed-article:18478111 | lifeskim:mentions | umls-concept:C1538633 | lld:lifeskim |
pubmed-article:18478111 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:18478111 | pubmed:dateCreated | 2008-5-14 | lld:pubmed |
pubmed-article:18478111 | pubmed:abstractText | Surgery and radiation are the mainstays of therapy for human gliomas that are the most common primary brain tumors. Most recently, cell culture and animal studies provided the first convincing evidence that radiation not only eliminates tumor cells, but also modulates the immune response and likely improves anti-tumor immunotherapy. | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:language | eng | lld:pubmed |
pubmed-article:18478111 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18478111 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18478111 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18478111 | pubmed:issn | 1932-6203 | lld:pubmed |
pubmed-article:18478111 | pubmed:author | pubmed-author:MeeseEckartE | lld:pubmed |
pubmed-article:18478111 | pubmed:author | pubmed-author:KellerAndreas... | lld:pubmed |
pubmed-article:18478111 | pubmed:author | pubmed-author:KetterRalfR | lld:pubmed |
pubmed-article:18478111 | pubmed:author | pubmed-author:LenhofHans-Pe... | lld:pubmed |
pubmed-article:18478111 | pubmed:author | pubmed-author:HeiselSabrina... | lld:pubmed |
pubmed-article:18478111 | pubmed:author | pubmed-author:KleinVeronika... | lld:pubmed |
pubmed-article:18478111 | pubmed:author | pubmed-author:PallaschChris... | lld:pubmed |
pubmed-article:18478111 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18478111 | pubmed:volume | 3 | lld:pubmed |
pubmed-article:18478111 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18478111 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18478111 | pubmed:pagination | e2164 | lld:pubmed |
pubmed-article:18478111 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:meshHeading | pubmed-meshheading:18478111... | lld:pubmed |
pubmed-article:18478111 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18478111 | pubmed:articleTitle | Increased seroreactivity to glioma-expressed antigen 2 in brain tumor patients under radiation. | lld:pubmed |
pubmed-article:18478111 | pubmed:affiliation | Department of Human Genetics, Saarland University Medical School, Homburg/Saar, Germany. | lld:pubmed |
pubmed-article:18478111 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18478111 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:51230 | entrezgene:pubmed | pubmed-article:18478111 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18478111 | lld:entrezgene |